
iSTAR Medical announces positive 5-year data from its STAR-GLOBAL trial for supraciliary MIGS device
Medtech company iSTAR Medical has announced positive 5-year data from its STAR-GLOBAL trial for the supraciliary minimally invasive glaucoma surgery (MIGS) device MINIject®.1 STAR-GLOBAL is an extension trial of the initial EU clinical trials investigating …